查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1451192

2024-2032 年按标籤类型、材料、应用、最终用途和地区分類的药品标籤市场报告

Pharmaceutical Labeling Market Report by Label Type, Material, Application, End Use, and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 143 Pages | 商品交期: 2-3个工作天内

价格

2023年全球药品标籤市场规模达到60亿美元。展望未来， IMARC Group预计到2032年市场规模将达到96亿美元，2024-2032年复合年增长率（CAGR）为5.2%。监管合规性和安全性、药品批准量的增加、药品的全球化、包装技术的重大进步以及对以患者为中心的日益关注是推动市场的一些主要因素。

药品标籤是製药行业的一个重要方面，涉及药品基本资讯的创建和呈现。这些资讯通常透过标籤、包装插页和随附文件来传达。药品标籤的主要目的是提供有关药物用途、剂量说明、潜在副作用、禁忌症、储存要求和其他相关安全资讯的清晰、准确和全面的详细资讯。有效的药品标籤不仅可以确保医疗保健专业人员和病人安全、适当地使用药物，还可以促进法规遵循和行业标准的遵守。

新药物和新疗法不断涌入市场，需要高效、及时的标籤流程。随着製药公司开发新药物并获得批准，对准确且资讯丰富的标籤的需求变得至关重要，以促进正确使用并最大限度地降低风险。此外，随着药品在全球范围内分销和销售，对标准化和多语言标籤的需求激增。标籤需要适应不同的语言和监管要求，以有效地迎合不同的市场。除此之外，製药业越来越重视以患者为中心的护理和资讯共享，导致了患者友善标籤的发展。清晰、易于理解的标籤使患者能够就其药物和治疗计划做出明智的决定。除此之外，假药对病人安全和产业信誉构成重大威胁。复杂的标籤解决方案，包括全像图和防篡改功能，有助于防止假药进入供应链。与此一致的是，标籤流程的自动化和数位化简化了操作，减少了错误，并加快了药品的上市时间。这些技术进步提高了标籤生态系统的效率和成本效益。

药品标籤市场趋势/驱动因素：

法规遵从性和安全性

FDA 和 EMA 等卫生当局製定的严格法规在塑造药品标籤格局方面发挥关键作用。这些法规旨在确保病患安全、最大限度降低风险并提高药品资讯的透明度。製药公司需要提供准确且最新的药品标籤信息，包括适应症、禁忌症、剂量说明和潜在副作用。不遵守这些规定可能会给公司带来严厉的处罚、法律诉讼和声誉损害。因此，药品标籤流程必须符合不断发展的监管指南，以维持合规性并维护病患安全标准。这一因素凸显了准确和全面的标籤在减轻对患者的潜在伤害和维护製药业诚信方面的关键性质。

药品核准量增加

不断扩大的新药品管道（包括新疗法和仿製药）是药品标籤市场成长的驱动力。随着新药获得监管机构的批准，有效标籤的需求变得至关重要。药品标籤是向医疗保健专业人员和患者传达重要讯息、促进安全和正确使用药物的主要手段。药品审批的快速步骤凸显了简化标籤流程的迫切性，以确保在产品上市时提供准确和最新的资讯。此外，每种药物的独特特性和预期用途需要量身定制的标籤方法，使标籤成为药物开发和商业化生命週期中不可或缺的一部分。

药品的快速全球化

随着製药公司将业务扩展到各个市场，他们必须应对不同的监管要求和语言考虑。标籤需要适应不同的语言、文化差异和当地法规，同时保持一致性和准确性。跨国製药公司面临协调跨地区标籤实践的挑战，同时确保遵守不同的监管环境。药品的全球化需要灵活的标籤策略，以适应不同的市场，同时不影响病人安全或法规遵守。这一因素强调了跨职能协作和高效标籤流程的重要性，以满足全球受众的多样化需求。

目录

第一章：前言

第 2 章：范围与方法

  • 研究目的
  • 利害关係人
  • 资料来源
    • 主要资源
    • 二手资料
  • 市场预测
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第 3 章：执行摘要

第 4 章：简介

  • 概述
  • 主要行业趋势

第 5 章：全球药品标籤市场

  • 市场概况
  • 市场业绩
  • COVID-19 的影响
  • 市场区隔：按标籤类型
  • 市场区隔：按材料
  • 市场区隔：按应用
  • 市场区隔：最终用途别
  • 市场区隔：按地区
  • 市场预测

第 6 章：市场区隔：按标籤类型

  • 压力标籤
    • 市场走向
    • 市场预测
  • 涂胶标籤
    • 市场走向
    • 市场预测
  • 袖标
    • 市场走向
    • 市场预测
  • 模内标籤
    • 市场走向
    • 市场预测
  • 其他的
    • 市场走向
    • 市场预测

第 7 章：市场区隔：依材料

  • 纸
    • 市场走向
    • 市场预测
  • 高分子薄膜
    • 市场走向
    • 市场预测
  • 其他的
    • 市场走向
    • 市场预测

第 8 章：市场区隔：按应用

  • 指导标籤
    • 市场走向
    • 市场预测
  • 装饰标籤
    • 市场走向
    • 市场预测
  • 功能标籤
    • 市场走向
    • 市场预测
  • 促销标籤
    • 市场走向
    • 市场预测
  • 其他的
    • 市场走向
    • 市场预测

第 9 章：市场区隔：最终用途别

  • 瓶子
    • 市场走向
    • 市场预测
  • 吸塑包装
    • 市场走向
    • 市场预测
  • 注射用容器
    • 市场走向
    • 市场预测
  • 预充式註射器
    • 市场走向
    • 市场预测
  • 预充式吸入器
    • 市场走向
    • 市场预测
  • 袋
    • 市场走向
    • 市场预测
  • 其他的
    • 市场走向
    • 市场预测

第 10 章：市场区隔：按地区

  • 欧洲
    • 市场走向
    • 市场预测
  • 北美洲
    • 市场走向
    • 市场预测
  • 亚太地区
    • 市场走向
    • 市场预测
  • 中东和非洲
    • 市场走向
    • 市场预测
  • 拉丁美洲
    • 市场走向
    • 市场预测

第 11 章：SWOT 分析

  • 概述
  • 优势
  • 弱点
  • 机会
  • 威胁

第 12 章：价值链分析

第 13 章：波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第 14 章：价格分析

第15章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • 3M
    • Avery Dennison Corporation
    • Bemis
    • CCL Industries
    • Essentra
    • LINTEC
    • SATO Holdings
    • Advanced Labels
    • Edwards Label
    • Jet Label
    • Consolidated Label
    • Axon
    • Clabro Label
    • Classic Label
    • Maverick Label
    • Metro Label
    • Progressive Label
    • MCC Label
    • Mercian Labels
    • Taylor Label
Product Code: SR112024A1559

The global pharmaceutical labeling market size reached US$ 6.0 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 9.6 Billion by 2032, exhibiting a growth rate (CAGR) of 5.2% during 2024-2032. The regulatory compliance and safety, rising drug approvals, globalization of pharmaceuticals, significant advances in packaging technology, and increasing focus on patient-centricity are some of the major factors propelling the market.

Pharmaceutical labeling is a critical aspect of the pharmaceutical industry that involves the creation and presentation of essential information on drug products. This information is typically conveyed through labels, packaging inserts, and accompanying documentation. The primary purpose of pharmaceutical labeling is to provide clear, accurate, and comprehensive details about a medication's uses, dosage instructions, potential side effects, contraindications, storage requirements, and other relevant safety information. Effective pharmaceutical labeling not only ensures the safe and appropriate use of medications by healthcare professionals and patients but also facilitates regulatory compliance and adherence to industry standards.

The continuous influx of new drugs and therapies entering the market demands efficient and timely labeling processes. As pharmaceutical companies develop and gain approvals for new medications, the need for accurate and informative labels becomes paramount to facilitate proper usage and minimize risks. Additionally, with pharmaceutical products being distributed and marketed globally, the demand for standardized and multilingual labeling has surged. Labels need to be adapted to various languages and regulatory requirements to effectively cater to diverse markets. Other than this, the increasing emphasis of the pharmaceutical industry on patient-centric care and information sharing has led to the development of patient-friendly labeling. Clear, easy-to-understand labels empower patients to make informed decisions about their medications and treatment plans. Besides this, counterfeit drugs pose a significant threat to patient safety and industry credibility. Sophisticated labeling solutions, including holograms and tamper-evident features, help prevent counterfeit drugs from entering the supply chain. In line with this, automation and digitalization in labeling processes have streamlined operations, reduced errors, and accelerated time-to-market for pharmaceutical products. These technological advancements drive efficiency and cost-effectiveness within the labeling ecosystem.

Pharmaceutical Labeling Market Trends/Drivers:

Regulatory Compliance and Safety

The stringent regulations set forth by health authorities, such as the FDA and EMA, play a pivotal role in shaping the pharmaceutical labeling landscape. These regulations are designed to ensure patient safety, minimize risks, and enhance transparency in drug information. Pharmaceutical companies are required to provide accurate and up-to-date information on drug labels, including indications, contraindications, dosage instructions, and potential side effects. Non-compliance with these regulations can result in severe penalties, legal actions, and reputational damage for companies. As a result, pharmaceutical labeling processes must align with evolving regulatory guidelines to maintain compliance and uphold patient safety standards. This factor highlights the critical nature of accurate and comprehensive labeling in mitigating potential harm to patients and maintaining the integrity of the pharmaceutical industry.

Rise in Drug Approvals

The ever-expanding pipeline of new pharmaceutical products, including novel therapies and generics, is a driving force behind the growth of the pharmaceutical labeling market. As new drugs receive approvals from regulatory agencies, the need for effective labeling becomes paramount. Pharmaceutical labels are the primary means of conveying essential information to healthcare professionals and patients, facilitating safe and proper usage of medications. The rapid pace of drug approvals underscores the urgency for streamlined labeling processes to ensure that accurate and up-to-date information is available at the time of product launch. Furthermore, each drug's unique characteristics and intended use require tailored labeling approaches, making labeling an integral part of the drug development and commercialization lifecycle.

Rapid Globalization of Pharmaceuticals

As pharmaceutical companies expand their reach into various markets, they must navigate diverse regulatory requirements and language considerations. Labels need to accommodate different languages, cultural nuances, and local regulations while maintaining consistency and accuracy. Multinational pharmaceutical companies face the challenge of harmonizing labeling practices across regions while ensuring compliance with varying regulatory landscapes. The globalization of pharmaceuticals necessitates agile labeling strategies that can adapt to different markets without compromising patient safety or regulatory adherence. This factor underscores the importance of cross-functional collaboration and efficient labeling processes to cater to the diverse needs of a global audience.

Pharmaceutical Labeling Industry Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global pharmaceutical labeling market report, along with forecasts at the global and regional levels for 2024-2032. Our report has categorized the market based on label type, material, application, and end use.

Breakup by Label Type:

Pressure-Sensitive Label

Glue-Applied Label

Sleeve Label

In-Mold Label

Others

Pressure-sensitive label dominates the market

The report has provided a detailed breakup and analysis of the market based on the label type. This includes pressure-sensitive label, glue-applied label, sleeve model, in-mold label, and others. According to the report, pressure-sensitive label represented the largest segment.

Pressure-sensitive labels offer a versatile and user-friendly labeling solution that is compatible with a wide range of packaging materials, including glass, plastic, and cardboard. This flexibility of application across various surfaces makes pressure-sensitive labels a preferred choice for pharmaceutical companies seeking consistency in labeling across their product portfolio. Moreover, pressure-sensitive labels eliminate the need for heat, solvents, or specialized equipment during application, streamlining the labeling process and reducing operational complexities. This factor contributes to enhanced efficiency and cost-effectiveness in pharmaceutical manufacturing and packaging workflows. Furthermore, pressure-sensitive labels accommodate the demand for customization and personalization in pharmaceutical packaging. They enable the incorporation of branding elements, regulatory information, barcodes, and even variable data, facilitating accurate tracking and traceability throughout the supply chain.

Breakup by Material:

Paper

Polymer Film

Others

Polymer film hold the largest share in the market

A detailed breakup and analysis of the market based on the material has also been provided in the report. This includes paper, polymer film, and others. According to the report, polymer film accounted for the largest market share.

Polymer films provide excellent printability and clarity, allowing for precise reproduction of intricate designs, branding elements, and vital drug information on labels. This clarity is vital for conveying crucial details to healthcare professionals and patients, ensuring accurate medication usage. Additionally, polymer films exhibit remarkable durability and resistance to environmental factors such as moisture, light, and temperature fluctuations. This resilience safeguards the integrity of the label and the information it carries throughout the product's lifecycle, thereby maintaining regulatory compliance and patient safety. Furthermore, polymer films offer compatibility with various label printing technologies, including digital and flexographic methods. This adaptability facilitates streamlined manufacturing processes, quicker turnaround times, and cost-effective label production. Moreover, polymer films are available in different thicknesses, finishes, and textures, allowing for customization based on specific packaging requirements and design preferences. This versatility enables pharmaceutical companies to create labels that align with their branding strategy while adhering to regulatory guidelines.

Breakup by Application:

Instructional Label

Decorative Label

Functional Label

Promotional Label

Others

The report has provided a detailed breakup and analysis of the market based on the application. This includes instructional label, decorative label, functional label, promotional label, and others.

The instructional label segment serves as a critical component of pharmaceutical labeling, providing comprehensive and clear guidance on the appropriate use and administration of medications. These labels convey vital information such as dosage instructions, usage guidelines, potential side effects, contraindications, and storage recommendations. The primary goal of instructional labels is to ensure patient safety by empowering healthcare professionals and patients with accurate information to make informed decisions about medication usage. Regulatory compliance plays a significant role in shaping instructional labels, as adherence to guidelines set by health authorities is essential to prevent errors and promote effective treatment outcomes.

While functional and instructional aspects remain paramount, decorative labels contribute to brand identity, differentiation, and market positioning. These labels often incorporate company logos, color schemes, and design elements that resonate with the target audience. By combining aesthetic creativity with functional information, decorative labels facilitate recognition in a crowded market and create a memorable impression on consumers. However, it's essential to strike a balance between aesthetics and the clarity of information to ensure that regulatory compliance and patient safety are not compromised.

The functional label segment encompasses labels that provide specialized features beyond basic information dissemination. These labels may include features such as tamper-evident seals, authentication elements, QR codes, RFID technology, and serialization. Functional labels play a pivotal role in ensuring product integrity, supply chain security, and patient safety. Tamper-evident seals, for instance, prevent unauthorized access to medication packaging, reducing the risk of tampering or counterfeiting. QR codes and RFID technology enhance traceability and enable patients to access additional information online. The functional label segment caters to the evolving needs of the pharmaceutical industry, aligning with advancements in technology and the increasing focus on patient engagement and product authenticity.

Breakup by End Use:

Bottles

Blister Packs

Parenteral Containers

Pre-Fillable Syringes

Pre-Fillable Inhalers

Pouches

Others

Bottles hold the largest share in the market

A detailed breakup and analysis of the market based on the end use has also been provided in the report. This includes bottles, blister packs, parenteral containers, pre-fillable syringes, pre-fillable inhalers, pouches, and others. According to the report, bottles accounted for the largest market share.

Bottles provide an effective barrier against external elements, such as moisture, light, and contaminants, preserving the potency and stability of pharmaceutical products. This protective feature ensures that medications remain safe and effective throughout their shelf life, a fundamental aspect of regulatory compliance and patient well-being. Furthermore, bottles are available in various sizes and materials, catering to the diverse needs of pharmaceutical companies. Their compatibility with different closure mechanisms, such as child-resistant caps, tamper-evident seals, and dispensing closures, enhances patient safety and regulatory adherence. Bottles also facilitate efficient labeling, allowing ample surface area for instructional, decorative, and functional labels. Their straightforward design supports clear communication of essential drug information to healthcare professionals and patients, aligning with the industry's focus on patient-centric care.

Breakup by Region:

North America

Europe

Asia Pacific

Latin America

Middle East and Africa

North America exhibits a clear dominance in the market

The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. According to the report, North America accounted for the largest market share.

One of the primary drivers is the robust pharmaceutical sector across the region, characterized by a high volume of drug production, research and development activities, and a mature healthcare ecosystem. The stringent regulatory framework established by organizations like the FDA necessitates comprehensive and accurate labeling to ensure patient safety and regulatory compliance. This emphasis on regulatory adherence has propelled the demand for sophisticated labeling solutions that effectively convey vital drug information to healthcare professionals and patients. Moreover, the North American market has witnessed substantial advancements in labeling technology, including digital printing, serialization, and smart labeling solutions. These innovations enhance traceability, supply chain security, and patient engagement, further amplifying the demand for cutting-edge labeling products and services. Additionally, the region's emphasis on patient-centric care and the growing focus on personalized medicine have heightened the need for clear and informative labeling. The pharmaceutical industry's commitment to transparency and effective communication aligns with the role of labeling in delivering accurate information to end-users.

Competitive Landscape:

Leading companies have invested in research and development to introduce innovative labeling solutions that incorporate advanced technologies. This includes the integration of smart features like QR codes, RFID, and tamper-evident seals to enhance traceability, authentication, and patient engagement. Additionally, to cater to diverse pharmaceutical product portfolios, key players have focused on providing customizable and personalized labeling options. This allows pharmaceutical companies to align labels with their branding strategies while complying with regulatory guidelines. Other than this, given the importance of regulatory compliance, key players offer expertise in navigating complex regulatory landscapes. They work closely with pharmaceutical companies to ensure that labels meet the requirements set forth by health authorities, preventing non-compliance-related setbacks. Besides this, numerous prominent players have expanded their global presence, offering multilingual labeling solutions tailored to different markets. This expansion addresses the globalization of pharmaceutical distribution and packaging while ensuring accurate communication to diverse audiences.

The market research report has provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

3M

Avery Dennison Corporation

Bemis

CCL Industries

Essentra

LINTEC

SATO Holdings

Advanced Labels

Edwards Label

Jet Label

Consolidated Label

Axon

Clabro Label

Classic Label

Maverick Label

Metro Label

Progressive Label

MCC Label

Mercian Labels

Taylor Label

Recent Developments:

Jet Label has recently been acquired by ProMach, a prominent player in the industry. This strategic move by ProMach is aimed at bolstering its presence in the niche yet burgeoning field of label printing and converting. By incorporating Jet Label into its operations, ProMach has effectively integrated an additional dimension to its existing framework.

Avery Dennison has developed a broad portfolio of tamper-evident and anti-counterfeiting label solutions, including destructible labels, box damage films and void labels, to help curb the drug counterfeiting trend

Key Questions Answered in This Report

  • 1. How big is the global pharmaceutical labeling market?
  • 2. What is the expected growth rate of the global pharmaceutical labeling market during 2024-2032?
  • 3. What are the key factors driving the global pharmaceutical labeling market?
  • 4. What has been the impact of COVID-19 on the global pharmaceutical labeling market?
  • 5. What is the breakup of the global pharmaceutical labeling market based on the label type?
  • 6. What is the breakup of the global pharmaceutical labeling market based on the material?
  • 7. What is the breakup of the global pharmaceutical labeling market based on the end use?
  • 8. What are the key regions in the global pharmaceutical labeling market?
  • 9. Who are the key players/companies in the global pharmaceutical labeling market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Pharmaceutical Labeling Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Breakup by Label Type
  • 5.5 Market Breakup by Material
  • 5.6 Market Breakup by Application
  • 5.7 Market Breakup by End Use
  • 5.8 Market Breakup by Region
  • 5.9 Market Forecast

6 Market Breakup by Label Type

  • 6.1 Pressure-Sensitive Label
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Glue-Applied Label
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Sleeve Label
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 In-Mold Label
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Others
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast

7 Market Breakup by Material

  • 7.1 Paper
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Polymer Film
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Others
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast

8 Market Breakup by Application

  • 8.1 Instructional Label
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Decorative Label
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Functional Label
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Promotional Label
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Others
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast

9 Market Breakup by End Use

  • 9.1 Bottles
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Blister Packs
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Parenteral Containers
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Pre-Fillable Syringes
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast
  • 9.5 Pre-Fillable Inhalers
    • 9.5.1 Market Trends
    • 9.5.2 Market Forecast
  • 9.6 Pouches
    • 9.6.1 Market Trends
    • 9.6.2 Market Forecast
  • 9.7 Others
    • 9.7.1 Market Trends
    • 9.7.2 Market Forecast

10 Market Breakup by Region

  • 10.1 Europe
    • 10.1.1 Market Trends
    • 10.1.2 Market Forecast
  • 10.2 North America
    • 10.2.1 Market Trends
    • 10.2.2 Market Forecast
  • 10.3 Asia Pacific
    • 10.3.1 Market Trends
    • 10.3.2 Market Forecast
  • 10.4 Middle East and Africa
    • 10.4.1 Market Trends
    • 10.4.2 Market Forecast
  • 10.5 Latin America
    • 10.5.1 Market Trends
    • 10.5.2 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 3M
    • 15.3.2 Avery Dennison Corporation
    • 15.3.3 Bemis
    • 15.3.4 CCL Industries
    • 15.3.5 Essentra
    • 15.3.6 LINTEC
    • 15.3.7 SATO Holdings
    • 15.3.8 Advanced Labels
    • 15.3.9 Edwards Label
    • 15.3.10 Jet Label
    • 15.3.11 Consolidated Label
    • 15.3.12 Axon
    • 15.3.13 Clabro Label
    • 15.3.14 Classic Label
    • 15.3.15 Maverick Label
    • 15.3.16 Metro Label
    • 15.3.17 Progressive Label
    • 15.3.18 MCC Label
    • 15.3.19 Mercian Labels
    • 15.3.20 Taylor Label

List of Figures

  • Figure 1: Global: Pharmaceutical Labeling Market: Major Drivers and Challenges
  • Figure 2: Global: Pharmaceutical Labeling Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Pharmaceutical Labeling Market: Breakup by Label Type (in %), 2023
  • Figure 4: Global: Pharmaceutical Labeling Market: Breakup by Material (in %), 2023
  • Figure 5: Global: Pharmaceutical Labeling Market: Breakup by Application (in %), 2023
  • Figure 6: Global: Pharmaceutical Labeling Market: Breakup by End Use (in %), 2023
  • Figure 7: Global: Pharmaceutical Labeling Market: Breakup by Region (in %), 2023
  • Figure 8: Global: Pharmaceutical Labeling Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 9: Global: Pharmaceutical Labeling Industry: SWOT Analysis
  • Figure 10: Global: Pharmaceutical Labeling Industry: Value Chain Analysis
  • Figure 11: Global: Pharmaceutical Labeling Industry: Porter's Five Forces Analysis
  • Figure 12: Global: Pharmaceutical Labeling (Pressure-Sensitive Label) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 13: Global: Pharmaceutical Labeling (Pressure-Sensitive Label) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 14: Global: Pharmaceutical Labeling (Glue-Applied Label) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 15: Global: Pharmaceutical Labeling (Glue-Applied Label) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 16: Global: Pharmaceutical Labeling (Sleeve Label) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 17: Global: Pharmaceutical Labeling (Sleeve Label) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 18: Global: Pharmaceutical Labeling (In-Mold Label) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 19: Global: Pharmaceutical Labeling (In-Mold Label) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 20: Global: Pharmaceutical Labeling (Other Label Types) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 21: Global: Pharmaceutical Labeling (Other Label Types) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 22: Global: Pharmaceutical Labeling (Paper) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 23: Global: Pharmaceutical Labeling (Paper) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 24: Global: Pharmaceutical Labeling (Polymer Film) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 25: Global: Pharmaceutical Labeling (Polymer Film) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 26: Global: Pharmaceutical Labeling (Other Materials) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 27: Global: Pharmaceutical Labeling (Other Materials) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 28: Global: Pharmaceutical Labeling (Instructional Label) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 29: Global: Pharmaceutical Labeling (Instructional Label) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 30: Global: Pharmaceutical Labeling (Decorative Label) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 31: Global: Pharmaceutical Labeling (Decorative Label) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 32: Global: Pharmaceutical Labeling (Functional Label) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 33: Global: Pharmaceutical Labeling (Functional Label) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 34: Global: Pharmaceutical Labeling (Promotional Label) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 35: Global: Pharmaceutical Labeling (Promotional Label) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 36: Global: Pharmaceutical Labeling (Other Applications) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 37: Global: Pharmaceutical Labeling (Other Applications) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 38: Global: Pharmaceutical Labeling (Bottles) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 39: Global: Pharmaceutical Labeling (Bottles) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 40: Global: Pharmaceutical Labeling (Blister Packs) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 41: Global: Pharmaceutical Labeling (Blister Packs) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 42: Global: Pharmaceutical Labeling (Parenteral Containers) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 43: Global: Pharmaceutical Labeling (Parenteral Containers) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 44: Global: Pharmaceutical Labeling (Pre-Fillable Syringes) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 45: Global: Pharmaceutical Labeling (Pre-Fillable Syringes) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 46: Global: Pharmaceutical Labeling (Pre-Fillable Inhalers) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 47: Global: Pharmaceutical Labeling (Pre-Fillable Inhalers) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 48: Global: Pharmaceutical Labeling (Pouches) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 49: Global: Pharmaceutical Labeling (Pouches) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 50: Global: Pharmaceutical Labeling (Other End Uses) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 51: Global: Pharmaceutical Labeling (Other End Uses) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 52: Europe: Pharmaceutical Labeling Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 53: Europe: Pharmaceutical Labeling Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 54: North America: Pharmaceutical Labeling Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 55: North America: Pharmaceutical Labeling Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 56: Asia Pacific: Pharmaceutical Labeling Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 57: Asia Pacific: Pharmaceutical Labeling Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 58: Middle East and Africa: Pharmaceutical Labeling Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 59: Middle East and Africa: Pharmaceutical Labeling Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 60: Latin America: Pharmaceutical Labeling Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 61: Latin America: Pharmaceutical Labeling Market Forecast: Sales Value (in Million US$), 2024-2032

List of Tables

  • Table 1: Global: Pharmaceutical Labeling Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Pharmaceutical Labeling Market Forecast: Breakup by Label Type (in Million US$), 2024-2032
  • Table 3: Global: Pharmaceutical Labeling Market Forecast: Breakup by Material (in Million US$), 2024-2032
  • Table 4: Global: Pharmaceutical Labeling Market Forecast: Breakup by Application (in Million US$), 2024-2032
  • Table 5: Global: Pharmaceutical Labeling Market Forecast: Breakup by End Use (in Million US$), 2024-2032
  • Table 6: Global: Pharmaceutical Labeling Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 7: Global: Pharmaceutical Labeling Market Structure
  • Table 8: Global: Pharmaceutical Labeling Market: Key Players